Virtus ETF Advisers’s Praxis Precision Medicines PRAX Stock Holding History

Virtus ETF Advisers’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$296K	Buy	+883	New	+$280K	0.11%	214
2025 Q1	–	Sell	-1,001	Closed	-$77K	–	697
2024 Q4	$77K	Sell	1,001 -1,296	-56%	-$93.8K	0.03%	344
2024 Q3	$132K	Buy	2,297 +37	+2%	+$2K	0.06%	341
2024 Q2	$93.5K	Buy	+2,260	New	+$107K	0.05%	342
2022 Q2	–	Sell	-568	Closed	-$87K	–	466
2022 Q1	$87K	Sell	568 -34	-6%	-$6.98K	0.04%	323
2021 Q4	$178K	Sell	602 -82	-12%	-$24.1K	0.07%	255
2021 Q3	$190K	Sell	684 -36	-5%	-$9.77K	0.08%	282
2021 Q2	$197K	Buy	+720	New	+$258K	0.08%	354

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Virtus ETF Advisers's PRAX Position: Q2 2026 in Review

Virtus ETF Advisers opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 883 shares worth $296K. The stake represents 0.11% of the portfolio and ranks #214 among its holdings. This is a return to the name: Virtus ETF Advisers previously reported a position in PRAX as recently as Q4 2024.

Virtus ETF Advisers first reported a position in PRAX in Q2 2021 and has held it in 8 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Virtus ETF Advisers held 883 shares of Praxis Precision Medicines worth $296K as of Q2 2026.
Praxis Precision Medicines was a new Virtus ETF Advisers position in Q2 2026.
Praxis Precision Medicines made up 0.11% of Virtus ETF Advisers's portfolio in Q2 2026, its #214 holding.
Virtus ETF Advisers first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 8 quarters since.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.